Issue link: https://www.e-digitaleditions.com/i/1287521
Tablets & Capsules September 2020 55 Eurofins adds Canadian manufacturing facility MISSISSAUGA, Canada—Eurof- ins, a pharmaceutical CDMO, com- pleted a 14,500-square-foot GMP manufacturing facility in Missis- sauga, Canada, expanding its existing drug product operation capabilities. The facility includes fully equipped pre-formulation and formulation development laboratories, a develop- ment suite, multiple GMP manufac- turing suites, clinical packaging, and warehousing. The addition supports the CDMO's development and clini- cal manufacturing of oral solid dosage forms, including highly potent APIs. Abitec acquires Larodan COLOMBUS, OH—Abitec, a manufacturer of specialty lipid ingre- dients, acquired research-grade lipid manufacturer Larodan, Stockholm, Sweden. The acquisition will advance Abitec into the field of Lipidomics and could offer researchers the capa- bilities to identify the various roles of lipids at the chemical level. Lonza expands particle engineering services B A S E L , S w i t z e r l a n d — L o n z a expanded its global particle engi- neering services at three sites. The company doubled the development capacity at its Monteggio, Switzer- land, micronization site, including an isolation glovebox, upgraded pro- cess controls, and expanded operator teams. The company also added a micronzation development wing to its Quakertown, PA, site and a phar- maceutical spray dryer for develop- ment projects to its Bend, OR, site. DuPont softgels receive Non- GMO Project certification WILMINGTON, DE—DuPont Nutrition & Biosciences has received Non-GMO Project Verified certi- fication for its SeaGel non-animal softgels. The Non-GMO Project is the only third-party verification program for non-GMO food, drug, and beauty products. To receive this certification, a supplier must pass a product evaluation that includes a ing, and consumer health products, will expand its site in Buenos Aires, Argentina. The expansion will add more than 11,000 square feet of pro- duction space that will be segregated and designed to handle cytotoxic and highly active products. New equip- ment includes two manufacturing ves- sels, a capsule filling line, and six dry- ing tunnels, increasing site capacity by 10 million doses per year. The expansion is forecast to be completed by December 2021. T h e c o m p a n y a l s o f i n i s h e d expanding its consumer health manu- facturing facilities in Strathroy, Can- ada, and Sorocaba, Brazil, both of which provide integrated formula- tion, manufacturing, and packaging services to the pharmaceutical, con- sumer health, and beauty industries. The expansions added softgel encap- sulation lines to both sites to increase the manufacturing capacity of Catal- ent's Vegicaps plant-based capsules and CosmoPod twist-off capsules. LGM acquires Nexgen ERLANGER, KY—LGM Pharma, an API sourcing and distribution company, acquired the formulation development and drug product con- tract manufacturing business unit of Nexgen Pharma, Irvine, CA. The acquisition includes Nexgen's manu- facturing and warehouse distribution facilities and employees in California and Texas as well as its formulation development, laboratory, and pilot plant manufacturing employees and facilities in Colorado. Omya completes expansion of Orgon site ORGON, France—Omya has expanded its calcium carbonate pro- duction plant in Orgon, France. The expansion increased capacity for the company's functionalized calcium carbonate product and added a pack- aging line and an onsite warehouse. At this ExciPact- and GFSI-certified facility, the company manufactures mineral grades for the pharmaceuti- cal, nutraceutical, and food industries. gamlentableting.com "Powder compression is a critical process in manufacturing the tablet dosage form. Although this process has been used routinely for over a century, problems related to powder compression in pharmaceutical formulation development and manufacturing persist." USP <1062> Tablet Compression Characterisation Formulate better to avoid sticking, picking, capping, low tablet hardness. Troubleshoot tableting problems faster, smarter, easier. Reduce production downtime, cost and waste. THE TABLETING PROBLEM THE PROVEN SOLUTION Gamlen's world- leading powder compaction analysis instruments